The prostate is a walnut-sized gland located behind the base of a man?s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics. This report contains market size and forecasts of Prostate Cancer Diagnostics in global, including the following market information:
Global Prostate Cancer Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Diagnostics market was valued at US$ 13820 million in 2022 and is projected to reach US$ 22870 million by 2029, at a CAGR of 7.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. Those key players got about 4% market shares. North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49%. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28%.
We surveyed the Prostate Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Diagnostics Market Segment Percentages, by Type, 2022 (%)
Tumor Biomarker Tests
Imaging
Biopsy
Other
Global Prostate Cancer Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Diagnostics Market Segment Percentages, by Application, 2022 (%)
Age Below 55
Age 55-75
Age Above 75
Global Prostate Cancer Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Prostate Cancer Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Diagnostics, market overview.
Chapter 2: Global Prostate Cancer Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnostics Overall Market Size
2.1 Global Prostate Cancer Diagnostics Market Size: 2022 VS 2029
2.2 Global Prostate Cancer Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnostics Players in Global Market
3.2 Top Global Prostate Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Tumor Biomarker Tests
4.1.3 Imaging
4.1.4 Biopsy
4.1.5 Other
4.2 By Type - Global Prostate Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Diagnostics Market Size, 2022 & 2029
5.1.2 Age Below 55
5.1.3 Age 55-75
5.1.4 Age Above 75
5.2 By Application - Global Prostate Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Prostate Cancer Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Prostate Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnostics Revenue, 2018-2029
6.3.2 US Prostate Cancer Diagnostics Market Size, 2018-2029
6.3.3 Canada Prostate Cancer Diagnostics Market Size, 2018-2029
6.3.4 Mexico Prostate Cancer Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnostics Revenue, 2018-2029
6.4.2 Germany Prostate Cancer Diagnostics Market Size, 2018-2029
6.4.3 France Prostate Cancer Diagnostics Market Size, 2018-2029
6.4.4 U.K. Prostate Cancer Diagnostics Market Size, 2018-2029
6.4.5 Italy Prostate Cancer Diagnostics Market Size, 2018-2029
6.4.6 Russia Prostate Cancer Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Prostate Cancer Diagnostics Market Size, 2018-2029
6.4.8 Benelux Prostate Cancer Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnostics Revenue, 2018-2029
6.5.2 China Prostate Cancer Diagnostics Market Size, 2018-2029
6.5.3 Japan Prostate Cancer Diagnostics Market Size, 2018-2029
6.5.4 South Korea Prostate Cancer Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Prostate Cancer Diagnostics Market Size, 2018-2029
6.5.6 India Prostate Cancer Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnostics Revenue, 2018-2029
6.6.2 Brazil Prostate Cancer Diagnostics Market Size, 2018-2029
6.6.3 Argentina Prostate Cancer Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnostics Revenue, 2018-2029
6.7.2 Turkey Prostate Cancer Diagnostics Market Size, 2018-2029
6.7.3 Israel Prostate Cancer Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Prostate Cancer Diagnostics Market Size, 2018-2029
6.7.5 UAE Prostate Cancer Diagnostics Market Size, 2018-2029
7 Prostate Cancer Diagnostics Companies Profiles
7.1 OPKO
7.1.1 OPKO Company Summary
7.1.2 OPKO Business Overview
7.1.3 OPKO Prostate Cancer Diagnostics Major Product Offerings
7.1.4 OPKO Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.1.5 OPKO Key News & Latest Developments
7.2 Genomic Health
7.2.1 Genomic Health Company Summary
7.2.2 Genomic Health Business Overview
7.2.3 Genomic Health Prostate Cancer Diagnostics Major Product Offerings
7.2.4 Genomic Health Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Genomic Health Key News & Latest Developments
7.3 Abbott
7.3.1 Abbott Company Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Prostate Cancer Diagnostics Major Product Offerings
7.3.4 Abbott Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Abbott Key News & Latest Developments
7.4 Beckman Coulter
7.4.1 Beckman Coulter Company Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Prostate Cancer Diagnostics Major Product Offerings
7.4.4 Beckman Coulter Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Beckman Coulter Key News & Latest Developments
7.5 Siemens Healthcare
7.5.1 Siemens Healthcare Company Summary
7.5.2 Siemens Healthcare Business Overview
7.5.3 Siemens Healthcare Prostate Cancer Diagnostics Major Product Offerings
7.5.4 Siemens Healthcare Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Siemens Healthcare Key News & Latest Developments
7.6 bioMeriux
7.6.1 bioMeriux Company Summary
7.6.2 bioMeriux Business Overview
7.6.3 bioMeriux Prostate Cancer Diagnostics Major Product Offerings
7.6.4 bioMeriux Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.6.5 bioMeriux Key News & Latest Developments
7.7 Roche
7.7.1 Roche Company Summary
7.7.2 Roche Business Overview
7.7.3 Roche Prostate Cancer Diagnostics Major Product Offerings
7.7.4 Roche Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Roche Key News & Latest Developments
7.8 MDx Health
7.8.1 MDx Health Company Summary
7.8.2 MDx Health Business Overview
7.8.3 MDx Health Prostate Cancer Diagnostics Major Product Offerings
7.8.4 MDx Health Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.8.5 MDx Health Key News & Latest Developments
7.9 DiaSorin
7.9.1 DiaSorin Company Summary
7.9.2 DiaSorin Business Overview
7.9.3 DiaSorin Prostate Cancer Diagnostics Major Product Offerings
7.9.4 DiaSorin Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.9.5 DiaSorin Key News & Latest Developments
7.10 Myriad Genetics
7.10.1 Myriad Genetics Company Summary
7.10.2 Myriad Genetics Business Overview
7.10.3 Myriad Genetics Prostate Cancer Diagnostics Major Product Offerings
7.10.4 Myriad Genetics Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Myriad Genetics Key News & Latest Developments
7.11 Ambry Genetics
7.11.1 Ambry Genetics Company Summary
7.11.2 Ambry Genetics Business Overview
7.11.3 Ambry Genetics Prostate Cancer Diagnostics Major Product Offerings
7.11.4 Ambry Genetics Prostate Cancer Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Ambry Genetics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Diagnostics Market Drivers in Global Market
Table 3. Prostate Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Diagnostics in Global Market
Table 5. Top Prostate Cancer Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Prostate Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Prostate Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Prostate Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Prostate Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Prostate Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Prostate Cancer Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. OPKO Company Summary
Table 31. OPKO Prostate Cancer Diagnostics Product Offerings
Table 32. OPKO Prostate Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. OPKO Key News & Latest Developments
Table 34. Genomic Health Company Summary
Table 35. Genomic Health Prostate Cancer Diagnostics Product Offerings
Table 36. Genomic Health Prostate Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Genomic Health Key News & Latest Developments
Table 38. Abbott Company Summary
Table 39. Abbott Prostate Cancer Diagnostics Product Offerings
Table 40. Abbott Prostate Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Abbott Key News & Latest Developments
Table 42. Beckman Coulter Company Summary
Table 43. Beckman Coulter Prostate Cancer Diagnostics Product Offerings
Table 44. Beckman Coulter Prostate Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Beckman Coulter Key News & Latest Developments
Table 46. Siemens Healthcare Company Summary
Table 47. Siemens Healthcare Prostate Cancer Diagnostics Product Offerings
Table 48. Siemens Healthcare Prostate Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Siemens Healthcare Key News & Latest Developments
Table 50. bioMeriux Company Summary
Table 51. bioMeriux Prostate Cancer Diagnostics Product Offerings
Table 52. bioMeriux Prostate Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. bioMeriux Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Prostate Cancer Diagnostics Product Offerings
Table 56. Roche Prostate Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. MDx Health Company Summary
Table 59. MDx Health Prostate Cancer Diagnostics Product Offerings
Table 60. MDx Health Prostate Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. MDx Health Key News & Latest Developments
Table 62. DiaSorin Company Summary
Table 63. DiaSorin Prostate Cancer Diagnostics Product Offerings
Table 64. DiaSorin Prostate Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. DiaSorin Key News & Latest Developments
Table 66. Myriad Genetics Company Summary
Table 67. Myriad Genetics Prostate Cancer Diagnostics Product Offerings
Table 68. Myriad Genetics Prostate Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Myriad Genetics Key News & Latest Developments
Table 70. Ambry Genetics Company Summary
Table 71. Ambry Genetics Prostate Cancer Diagnostics Product Offerings
Table 72. Ambry Genetics Prostate Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. Ambry Genetics Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Diagnostics Segment by Type in 2022
Figure 2. Prostate Cancer Diagnostics Segment by Application in 2022
Figure 3. Global Prostate Cancer Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prostate Cancer Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnostics Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Prostate Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Prostate Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 16. US Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 28. China Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Prostate Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Prostate Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. OPKO Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Genomic Health Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Abbott Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Beckman Coulter Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Siemens Healthcare Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. bioMeriux Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Roche Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. MDx Health Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. DiaSorin Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Myriad Genetics Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Ambry Genetics Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
